AbbVie's upadacitinib successful in late-stage ulcerative colitis study
February 22 2021 - 8:17AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2024 to May 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From May 2023 to May 2024